H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Microbiology D-index 44 Citations 5,714 132 World Ranking 2871 National Ranking 1159

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Virus
  • Antibody

Edward Tabor focuses on Virology, Hepatitis B virus, Immunology, Hepatocellular carcinoma and HBsAg. His study involves Hepatitis B, Hepatitis, Viral disease, Hepatitis A and Hepatitis b surface antigen, a branch of Virology. His research on Hepatitis B virus concerns the broader Virus.

His research on Immunology focuses in particular on Viral hepatitis. Edward Tabor works mostly in the field of Hepatocellular carcinoma, limiting it down to topics relating to Pathology and, in certain cases, Cell culture. His study focuses on the intersection of HBsAg and fields such as Antigen with connections in the field of Antibody, Hemodialysis and Convalescence.

His most cited work include:

  • TRANSMISSION OF NON-A, NON-B HEPATITIS FROM MAN TO CHIMPANZEE (258 citations)
  • Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection. (233 citations)
  • Vascularization of small hepatocellular carcinomas: correlation with differentiation (121 citations)

What are the main themes of his work throughout his whole career to date?

Edward Tabor spends much of his time researching Virology, Immunology, Hepatitis B virus, Hepatitis and Hepatitis B. He has researched Virology in several fields, including Hepatocellular carcinoma, Antibody and Antigen. His Immunology research is multidisciplinary, incorporating elements of Transmission and Internal medicine.

His Hepatitis B virus study combines topics in areas such as Mutation and Titer. His research on Hepatitis also deals with topics like

  • Inoculation which is related to area like Immunity,
  • Vaccination that intertwine with fields like Isocitric acid. The study incorporates disciplines such as Hepatitis B vaccine, Hepatitis B antibody, Viral disease, Microbiology and Infectivity in addition to Hepatitis B.

He most often published in these fields:

  • Virology (82.61%)
  • Immunology (55.28%)
  • Hepatitis B virus (43.48%)

What were the highlights of his more recent work (between 1998-2016)?

  • Virology (82.61%)
  • Virus (20.50%)
  • Immunology (55.28%)

In recent papers he was focusing on the following fields of study:

Virology, Virus, Immunology, Hepatitis C virus and Hepatocellular carcinoma are his primary areas of study. His work in Virology tackles topics such as Antibody which are related to areas like Hepatitis B. His work on Hepacivirus, Flaviviridae and Transfusion reaction as part of general Immunology study is frequently linked to Technological evolution, bridging the gap between disciplines.

As a part of the same scientific family, he mostly works in the field of Hepatitis C virus, focusing on Serology and, on occasion, Nested polymerase chain reaction. His studies examine the connections between HBsAg and genetics, as well as such issues in Antigen, with regards to Hepatitis B immune globulin. His studies deal with areas such as Liver disease, Transfusion transmitted virus and Hepatitis as well as Hepatitis B virus.

Between 1998 and 2016, his most popular works were:

  • Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection. (233 citations)
  • Vascularization of small hepatocellular carcinomas: correlation with differentiation (121 citations)
  • The epidemiology of virus transmission by plasma derivatives: clinical studies verifying the lack of transmission of hepatitis B and C viruses and HIV type 1. (114 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Virus
  • Gene

His scientific interests lie mostly in Immunology, Virology, HBsAg, Orthohepadnavirus and Hepadnaviridae. His study in the field of Virus inactivation also crosses realms of Public economics, Regulatory policy and Technological evolution. His work on Viral disease as part of general Virology research is often related to Nat, thus linking different fields of science.

His work carried out in the field of Viral disease brings together such families of science as Viremia, Hepatitis b surface antigen and Viral load. His biological study spans a wide range of topics, including Seroconversion and Immunization, Antigen. His Orthohepadnavirus research is multidisciplinary, relying on both Transmission, Hepatitis B and Hepacivirus.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

TRANSMISSION OF NON-A, NON-B HEPATITIS FROM MAN TO CHIMPANZEE

Edward Tabor;JacquesA. Drucker;JayH. Hoofnagle;Milton April.
The Lancet (1978)

397 Citations

Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection.

Robin Biswas;Edward Tabor;Chu Chieh Hsia;David J. Wright.
Transfusion (2003)

345 Citations

Vascularization of small hepatocellular carcinomas: correlation with differentiation

Y. Nakashima;O. Nakashima;C. C. Hsia;M. Kojiro.
Liver (1999)

182 Citations

The epidemiology of virus transmission by plasma derivatives: clinical studies verifying the lack of transmission of hepatitis B and C viruses and HIV type 1.

E. Tabor.
Transfusion (1999)

176 Citations

Transmission of non-A, non-B hepatitis.

Jay H. Hoofnagle;Robert J. Gerety;Edward Tabor;Stephen M. Feinstone.
Annals of Internal Medicine (1977)

173 Citations

Tumor suppressor genes, growth factor genes, and oncogenes in hepatitis B virus-associated hepatocellular carcinoma.

Edward Tabor.
Journal of Medical Virology (1994)

161 Citations

Hepatitis B Virus Infection and Primary Hepatocellular Carcinoma

Edward Tabor;Robert J. Gerety;Charles L. Vogel;Anne C. Bayley.
Journal of the National Cancer Institute (1977)

151 Citations

HEPATITIS B INFECTION IN HOUSEHOLDS OF CHRONIC CARRIERS OF HEPATITIS B SURFACE ANTIGEN FACTORS ASSOCIATED WITH PREVALENCE OF INFECTION

Roger H. Bernier;Richard Sampliner;Robert Gerety;Edward Tabor.
American Journal of Epidemiology (1982)

134 Citations

ACUTE NON-A, NON-B HEPATITIS: SPECIFIC ULTRASTRUCTURAL ALTERATIONS IN ENDOPLASMIC RETICULUM OF INFECTED HEPATOCYTES

D. Jackson;E. Tabor;R.J. Gerety.
The Lancet (1979)

131 Citations

Neutralization of hepatitis B virus infectivity by a murine monoclonal antibody: an experimental study in the chimpanzee.

Sten Iwarson;Edward Tabor;Howard C. Thomas;Allison Goodall.
Journal of Medical Virology (1985)

124 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Edward Tabor

Robert H. Purcell

Robert H. Purcell

National Institutes of Health

Publications: 42

Michael P. Busch

Michael P. Busch

University of California, San Francisco

Publications: 28

Arie J. Zuckerman

Arie J. Zuckerman

University College London

Publications: 22

Jules L. Dienstag

Jules L. Dienstag

Harvard University

Publications: 20

Alfred M. Prince

Alfred M. Prince

New York Blood Center

Publications: 20

Jean-Pierre Allain

Jean-Pierre Allain

University of Cambridge

Publications: 20

Harvey J. Alter

Harvey J. Alter

National Institutes of Health

Publications: 16

Michael Houghton

Michael Houghton

University of Alberta

Publications: 16

John L. Gerin

John L. Gerin

Georgetown University Medical Center

Publications: 15

Roger Y. Dodd

Roger Y. Dodd

American Red Cross

Publications: 15

Hans Popper

Hans Popper

Icahn School of Medicine at Mount Sinai

Publications: 15

Masamichi Kojiro

Masamichi Kojiro

Kurume University

Publications: 14

Roger Williams

Roger Williams

Foundation for Liver Research

Publications: 14

Miriam J. Alter

Miriam J. Alter

Centers for Disease Control and Prevention

Publications: 14

Daniel W. Bradley

Daniel W. Bradley

Centers for Disease Control and Prevention

Publications: 13

Dimitrios Trichopoulos

Dimitrios Trichopoulos

Harvard University

Publications: 13

Something went wrong. Please try again later.